Glaukos Corporation (GKOS)
USD 82.27
(-4.42%)
USD 82.27
(-4.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 940.41 Million USD | -6.18% |
| 2022 | 1 Billion USD | -4.51% |
| 2021 | 1.04 Billion USD | 4.4% |
| 2020 | 1 Billion USD | 22.86% |
| 2019 | 818.4 Million USD | 295.42% |
| 2018 | 206.97 Million USD | 24.8% |
| 2017 | 165.83 Million USD | 23.42% |
| 2016 | 134.37 Million USD | 15.18% |
| 2015 | 116.66 Million USD | 348.33% |
| 2014 | 26.02 Million USD | -15.73% |
| 2013 | 30.87 Million USD | 497.81% |
| 2012 | 5.16 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 919.67 Million USD | -1.46% |
| 2024 Q1 | 933.33 Million USD | -0.75% |
| 2024 Q3 | 926.54 Million USD | 0.75% |
| 2023 Q3 | 948.63 Million USD | -0.85% |
| 2023 Q1 | 972.59 Million USD | -2.97% |
| 2023 Q2 | 956.74 Million USD | -1.63% |
| 2023 Q4 | 940.41 Million USD | -0.87% |
| 2023 FY | 940.41 Million USD | -6.18% |
| 2022 Q4 | 1 Billion USD | -0.6% |
| 2022 Q2 | 1.03 Billion USD | -1.98% |
| 2022 Q3 | 1 Billion USD | -2.21% |
| 2022 Q1 | 1.05 Billion USD | 0.23% |
| 2022 FY | 1 Billion USD | -4.51% |
| 2021 Q1 | 1.02 Billion USD | 1.72% |
| 2021 FY | 1.04 Billion USD | 4.4% |
| 2021 Q4 | 1.04 Billion USD | -1.36% |
| 2021 Q3 | 1.06 Billion USD | 1.95% |
| 2021 Q2 | 1.04 Billion USD | 2.05% |
| 2020 Q3 | 994.51 Million USD | -0.12% |
| 2020 Q4 | 1 Billion USD | 1.1% |
| 2020 FY | 1 Billion USD | 22.86% |
| 2020 Q1 | 779.72 Million USD | -4.73% |
| 2020 Q2 | 995.73 Million USD | 27.7% |
| 2019 Q4 | 818.4 Million USD | 166.2% |
| 2019 Q1 | 228.03 Million USD | 10.18% |
| 2019 Q3 | 307.43 Million USD | 1.77% |
| 2019 Q2 | 302.08 Million USD | 32.47% |
| 2019 FY | 818.4 Million USD | 295.42% |
| 2018 Q1 | 163.35 Million USD | -1.5% |
| 2018 Q4 | 206.97 Million USD | 8.65% |
| 2018 Q3 | 190.5 Million USD | 11.34% |
| 2018 Q2 | 171.09 Million USD | 4.74% |
| 2018 FY | 206.97 Million USD | 24.8% |
| 2017 Q1 | 137.9 Million USD | 2.63% |
| 2017 FY | 165.83 Million USD | 23.42% |
| 2017 Q4 | 165.83 Million USD | 8.67% |
| 2017 Q3 | 152.61 Million USD | 4.87% |
| 2017 Q2 | 145.52 Million USD | 5.53% |
| 2016 Q4 | 134.37 Million USD | 3.96% |
| 2016 Q2 | 124.09 Million USD | 6.69% |
| 2016 Q1 | 116.31 Million USD | -0.29% |
| 2016 FY | 134.37 Million USD | 15.18% |
| 2016 Q3 | 129.25 Million USD | 4.15% |
| 2015 Q1 | 28.25 Million USD | 8.58% |
| 2015 Q2 | 128.17 Million USD | 353.66% |
| 2015 FY | 116.66 Million USD | 348.33% |
| 2015 Q4 | 116.66 Million USD | -0.87% |
| 2015 Q3 | 117.68 Million USD | -8.18% |
| 2014 Q1 | 27.79 Million USD | -9.98% |
| 2014 FY | 26.02 Million USD | -15.73% |
| 2014 Q4 | 26.02 Million USD | 0.0% |
| 2014 Q2 | 26.69 Million USD | -3.95% |
| 2013 FY | 30.87 Million USD | 497.81% |
| 2013 Q4 | 30.87 Million USD | 0.0% |
| 2013 Q3 | 30.87 Million USD | 0.0% |
| 2012 FY | 5.16 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 98.716% |
| Allurion Technologies Inc. | 71.71 Million USD | -1211.376% |
| Artivion, Inc. | 792.39 Million USD | -18.68% |
| Avanos Medical, Inc. | 1.69 Billion USD | 44.433% |
| Butterfly Network, Inc. | 304.27 Million USD | -209.068% |
| Butterfly Network, Inc. | 304.27 Million USD | -209.068% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 92.354% |
| Boston Scientific Corporation | 35.13 Billion USD | 97.324% |
| CONMED Corporation | 2.3 Billion USD | 59.113% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | 89.956% |
| Paragon 28, Inc. | 340.69 Million USD | -176.025% |
| Globus Medical, Inc. | 5.08 Billion USD | 81.51% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -38.948% |
| Integer Holdings Corporation | 2.94 Billion USD | 68.042% |
| Medtronic plc | 89.98 Billion USD | 98.955% |
| Myomo, Inc. | 14.58 Million USD | -6349.334% |
| Nevro Corp. | 635.71 Million USD | -47.931% |
| Owlet, Inc. | 44.12 Million USD | -2031.346% |
| Penumbra, Inc. | 1.55 Billion USD | 39.574% |
| Vicarious Surgical Inc. | 119.86 Million USD | -684.568% |
| Smith & Nephew plc | 9.98 Billion USD | 90.584% |
| Sonendo, Inc. | 78.16 Million USD | -1103.191% |
| STERIS plc | 11.06 Billion USD | 91.5% |
| Stryker Corporation | 39.91 Billion USD | 97.644% |
| Vapotherm, Inc. | 77.61 Million USD | -1111.608% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 95.625% |